178 related articles for article (PubMed ID: 23851337)
1. The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis.
Shirazi F; Kontoyiannis DP
Eukaryot Cell; 2013 Sep; 12(9):1225-34. PubMed ID: 23851337
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis.
Shirazi F; Pontikos MA; Walsh TJ; Albert N; Lewis RE; Kontoyiannis DP
Antimicrob Agents Chemother; 2013 Sep; 57(9):4360-8. PubMed ID: 23817366
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against
Shirazi F; Kontoyiannis DP
Microb Cell; 2014 Jun; 1(6):179-188. PubMed ID: 28357242
[No Abstract] [Full Text] [Related]
4. Mitochondrial respiratory pathways inhibition in Rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis.
Shirazi F; Kontoyiannis DP
PLoS One; 2013; 8(5):e63393. PubMed ID: 23696824
[TBL] [Abstract][Full Text] [Related]
5. In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
Narreddy S; Manavathu E; Chandrasekar PH; Alangaden GJ; Revankar SG
J Antimicrob Chemother; 2010 Apr; 65(4):701-3. PubMed ID: 20130026
[TBL] [Abstract][Full Text] [Related]
6. In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
Dannaoui E; Schwarz P; Lortholary O
Antimicrob Agents Chemother; 2009 Aug; 53(8):3549-51. PubMed ID: 19451295
[TBL] [Abstract][Full Text] [Related]
7. Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Alastruey-Izquierdo A; Castelli MV; Cuesta I; Monzon A; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2009 Apr; 53(4):1686-9. PubMed ID: 19171801
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.
Lewis RE; Ben-Ami R; Best L; Albert N; Walsh TJ; Kontoyiannis DP
J Infect Dis; 2013 Mar; 207(5):834-41. PubMed ID: 23242544
[TBL] [Abstract][Full Text] [Related]
9. In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
Schwarz P; Schwarz PV; Felske-Zech H; Dannaoui E
J Antimicrob Chemother; 2019 Jul; 74(7):1921-1927. PubMed ID: 30934052
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.
Espinel-Ingroff A; Chakrabarti A; Chowdhary A; Cordoba S; Dannaoui E; Dufresne P; Fothergill A; Ghannoum M; Gonzalez GM; Guarro J; Kidd S; Lass-Flörl C; Meis JF; Pelaez T; Tortorano AM; Turnidge J
Antimicrob Agents Chemother; 2015 Mar; 59(3):1745-50. PubMed ID: 25583714
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
Gao L; Sun Y; He C; Zeng T; Li M
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923863
[No Abstract] [Full Text] [Related]
12. Activity of deferasirox in Mucorales: influences of species and exogenous iron.
Lewis RE; Pongas GN; Albert N; Ben-Ami R; Walsh TJ; Kontoyiannis DP
Antimicrob Agents Chemother; 2011 Jan; 55(1):411-3. PubMed ID: 20956598
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales.
Vitale RG; de Hoog GS; Schwarz P; Dannaoui E; Deng S; Machouart M; Voigt K; van de Sande WW; Dolatabadi S; Meis JF; Walther G
J Clin Microbiol; 2012 Jan; 50(1):66-75. PubMed ID: 22075600
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of posaconazole against clinical isolates of dermatophytes.
Barchiesi F; Arzeni D; Camiletti V; Simonetti O; Cellini A; Offidani AM; Scalise G
J Clin Microbiol; 2001 Nov; 39(11):4208-9. PubMed ID: 11682563
[TBL] [Abstract][Full Text] [Related]
15. Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
Bellanger AP; Albert ND; Lewis RE; Walsh TJ; Kontoyiannis DP
Antimicrob Agents Chemother; 2015 Dec; 59(12):7830-2. PubMed ID: 26392499
[TBL] [Abstract][Full Text] [Related]
16. Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran.
Vaezi A; Walther G; Kurzai O; Mahdi D; Dadashzadeh M; Nasri E; Diba K; Badali H; Fakhim H
Mycoses; 2021 Jul; 64(7):780-787. PubMed ID: 33835599
[TBL] [Abstract][Full Text] [Related]
17. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
Simitsopoulou M; Georgiadou E; Walsh TJ; Roilides E
Med Mycol; 2010 Aug; 48(5):720-4. PubMed ID: 20100138
[TBL] [Abstract][Full Text] [Related]
18. A Novel Resistance Pathway for Calcineurin Inhibitors in the Human-Pathogenic Mucorales Mucor circinelloides.
Vellanki S; Billmyre RB; Lorenzen A; Campbell M; Turner B; Huh EY; Heitman J; Lee SC
mBio; 2020 Jan; 11(1):. PubMed ID: 31992620
[TBL] [Abstract][Full Text] [Related]
19. Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes.
Gil-Lamaignere C; Hess R; Salvenmoser S; Heyn K; Kappe R; Müller FM
J Antimicrob Chemother; 2005 Jun; 55(6):1016-9. PubMed ID: 15883179
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility profiles of amphotericin B and posaconazole against clinically relevant mucorales species under hypoxic conditions.
Maurer E; Binder U; Sparber M; Lackner M; Caramalho R; Lass-Flörl C
Antimicrob Agents Chemother; 2015 Feb; 59(2):1344-6. PubMed ID: 25451049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
